The first 2 authors contributed equally to this article.
The degree of tumor volume reduction during the early phase of induction chemotherapy is an independent prognostic factor in patients with high-risk neuroblastoma
Article first published online: 5 SEP 2012
Copyright © 2012 American Cancer Society
Volume 119, Issue 3, pages 656–664, 1 February 2013
How to Cite
Yoo, S. Y., Kim, J.-S., Sung, K. W., Jeon, T. Y., Choi, J. Y., Moon, S. H., Son, M. H., Lee, S. H., Yoo, K. H. and Koo, H. H. (2013), The degree of tumor volume reduction during the early phase of induction chemotherapy is an independent prognostic factor in patients with high-risk neuroblastoma. Cancer, 119: 656–664. doi: 10.1002/cncr.27775
- Issue published online: 22 JAN 2013
- Article first published online: 5 SEP 2012
- Manuscript Revised: 12 JUL 2012
- Manuscript Accepted: 12 JUL 2012
- Manuscript Received: 11 APR 2012
- 4Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial. Blood. 2003; 101: 64-70., , , et al.
- 5Grade of chemotherapy-induced necrosis as a predictor of local and systemic control in 881 patients with non-metastatic osteosarcoma of the extremities treated with neoadjuvant chemotherapy in a single institution. Eur J Cancer. 2005; 41: 2079-2085., , , et al.
- 16Comparison of 123I-metaiodobenzylguanidine (MIBG) and 131I-MIBG semi-quantitative scores in predicting survival in patients with stage 4 neuroblastoma: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2011; 56: 1041-1045., , , et al.
- 19Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report from the Children's Cancer Group. J Clin Oncol. 1997; 15: 2222-2230., , , , , .